iSpecimen Inc. Debt Securities, Available-for-sale, Unrealized Gain
iSpecimen Inc. (ISPC) reported Debt Securities, Available-for-sale, Unrealized Gain of $37.25 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-07.
Financial Statements › Income Statement › Other Income
us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedGain · last filed 2025-04-14
- iSpecimen Inc. debt securities, available-for-sale, unrealized gain for the quarter ending 2024-03-31 was $37.25K, a 97.68% increase year-over-year.
- iSpecimen Inc. debt securities, available-for-sale, unrealized gain for the quarter ending 2023-12-31 was $3.46K.
- iSpecimen Inc. debt securities, available-for-sale, unrealized gain for the quarter ending 2023-09-30 was $6.45K.
- iSpecimen Inc. debt securities, available-for-sale, unrealized gain for the quarter ending 2023-06-30 was $7.39K.
- iSpecimen Inc. debt securities, available-for-sale, unrealized gain for fiscal 2023 was $36.14K.
| Period end | Debt Securities, Available-for-sale, Unrealized Gain 3 month | Debt Securities, Available-for-sale, Unrealized Gain 6 month | Debt Securities, Available-for-sale, Unrealized Gain 9 month | Debt Securities, Available-for-sale, Unrealized Gain 12 month |
|---|---|---|---|---|
| 2024-03-31 | $37.25K 10-Q · filed 2024-05-07 | $40.70K derived: sum of 2 quarters · filed 2025-04-14 | $47.16K derived: sum of 3 quarters · filed 2025-04-14 | $54.54K derived: sum of 4 quarters · filed 2025-04-14 |
| 2023-12-31 | $3.46K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-14 | $9.91K derived: sum of 2 quarters · filed 2025-04-14 | $17.30K derived: sum of 3 quarters · filed 2025-04-14 | $36.14K 10-K · filed 2025-04-14 |
| 2023-09-30 | $6.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $13.84K derived: sum of 2 quarters · filed 2023-11-02 | $32.68K 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $7.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $26.23K 10-Q · filed 2023-08-02 | ||
| 2023-03-31 | $18.84K 10-Q · filed 2023-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |